Does berberine help weight loss? What the trials measured

Share

Email article

Berberine trials measured body weight, body mass index (BMI) and waist circumference, often alongside blood sugar and blood fats; the two older individual trials discussed here enrolled people with diabetes or metabolic syndrome.[1][2][3] A 2020 review included 12 trials overall. In the five that measured body weight, the average difference against control was −2.07 kg, and NCCIH says more high-quality research is needed before firm conclusions.[1][4]

Three kinds of outcome, kept apart

OutcomeWhat the evidence showsSource
Body weight−2.07 kg on average across 5 randomized trials that measured weightAsbaghi 2020[1]
BMI−0.47 kg/m² on averageAsbaghi 2020[1]
Waist circumference−1.08 cm on averageAsbaghi 2020[1]
Liver enzymes (ALT, AST)No significant changeAsbaghi 2020[1]
Body weight by dose and lengthEffects mainly above 1 gram a day and beyond 8 weeks2022 review summarized by NCCIH[4]
Blood sugarHbA1c fell from 9.5% to 7.5% in 3 months in adults with new type 2 diabetes; weight was not reported in the abstractYin 2008[2]

Averages are differences against control groups in the pooled analysis; the 2008 figures are before-and-after values in the berberine group.[1][2]

Who was studied, and with what

  • People with metabolic conditions. One 52-week trial enrolled 136 people with obesity, type 2 diabetes and metabolic syndrome.[3] The diabetes trial enrolled adults with new or poorly controlled diabetes.[2]
  • A combination product. That 52-week trial tested berberine combined with milk thistle (Silybum marianum), so its improvements in waist size, abdominal fat measured by bioimpedance and blood markers describe the combination, not berberine alone.[3]
  • Other measures in the same trials. The pooled analysis does not say in its abstract how diet or exercise advice differed between groups; that limits what the averages can show about berberine by itself.[1]
  • Size of the change. The average of about 2 kg pools trials with different groups and doses.[1]

A larger, more recent trial

In a 2026 placebo-controlled trial, 337 adults with obesity and fatty liver disease but without diabetes received berberine 1 g a day or placebo for six months. Berberine did not produce greater weight loss: the difference between groups was 0.05 kg (95% CI −0.74 to 0.84). Visceral fat and liver fat, the main measures, also showed no significant benefit.[5] These results describe that group and do not cover every condition.[5]

What it adds up to

NCCIH states that additional high-quality research would be needed to reach definite conclusions about whether berberine reduces weight and BMI.[4]

Before you use berberine

  • Medicines. Berberine has been shown to interact with cyclosporine; see berberine and medicines in the berberine guide.[4] If you take diabetes medicines, discuss berberine with your clinician, since trials measured its effect on blood sugar.[2]
  • Pregnancy, breastfeeding and infants. NCCIH states that berberine is likely to be unsafe for infants and may be unsafe during pregnancy or breastfeeding.[4]
  • Digestive effects. In the diabetes trial, across the berberine monotherapy and add-on groups, 20 of 58 patients (34.5%) reported gastrointestinal adverse events; 14 patients needed a dose reduction because of these effects.[2]

Information, not a prescription. Do not start, stop or combine supplements or medicines on your own.

More about berberine

Sources

  1. Asbaghi O et al. The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: a systematic review and meta-analysis of randomized controlled trials. Clinical Nutrition ESPEN, 2020;38:43–49. https://doi.org/10.1016/j.clnesp.2020.04.010 ↩
  2. Yin J et al. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism, 2008;57:712–717. https://doi.org/10.1016/j.metabol.2008.01.013 ↩
  3. Guarino G et al. Bioimpedance analysis, metabolic effects and safety of the association Berberis aristata/Bilybum marianum: a 52-week double-blind, placebo-controlled study in obese patients with type 2 diabetes. J Biol Regul Homeost Agents, 2017;31:495–502. https://pubmed.ncbi.nlm.nih.gov/28685558/ ↩
  4. NCCIH. Berberine and Weight Loss: What You Need To Know. https://www.nccih.nih.gov/health/berberine-and-weight-loss-what-you-need-to-know ↩
  5. Lei et al. Berberine in adults with obesity and fatty liver disease (BRAVO), randomized placebo-controlled trial. JAMA Network Open, 2026. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2844037 ↩

You may quote, republish or translate this article under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/): credit "Verateca", link to this page and indicate changes, including translations. Quotes from NIH, FDA and other sources, label texts and prices are not covered by this license.